Lazard
LAZ · NYSE
About LAZ
- Employees
- 3,309
- Headquarters
- New York City, New York
- Listed
- May 5, 2005
- Sector
- Financials
- Industry
- Capital Markets
- Website
- lazard.com
LAZ key statistics
- Market cap
- 3.57B
- Price-earnings ratio
- 17.46
- Dividend yield
- 5.36%
- Average volume
- 1.65M
- Volume
- 1.47M
- Open price
- $35.54
- High today
- $37.39
- Low today
- $35.32
- 52 Week high
- $58.75
- 52 Week low
- $34.13
Lazard (LAZ) at a glance
Lazard (LAZ) last traded at $36.67, with a market cap of 3.57B, a price-to-earnings ratio of 17.46 and a dividend yield of 5.36%.
Today the stock has traded between $35.32 and $37.39. The current price is 3.8% above the day's low and 1.9% below its high.
Volume so far is 1.47M shares, in line with the average of 1.65M shares a day.
Over the past year Lazard has ranged from $34.13 to $58.75, and now sits 10% of the way up that range.
Lazard met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.12 per share against an estimate of $0.3564.
The average analyst price target is $47.56, 29.7% above the current price, from 7 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy28.6%
- Hold28.6%
- Sell42.9%
- Low
- $36.36
- Now
- $36.67
- High
- $63.00
LAZ earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 30.5% on average.
- Q3 FY24: reported $0.38 per share against an estimate of $0.3997
- Q4 FY24: reported $0.78 per share against an estimate of $0.558
- Q1 FY25: reported $0.56 per share against an estimate of $0.3823
- Q2 FY25: reported $0.52 per share against an estimate of $0.4016
- Q3 FY25: reported $0.56 per share against an estimate of $0.4568
- Q4 FY25: reported $0.80 per share against an estimate of $0.7018
- Q1 FY26: reported $0.42 per share against an estimate of $0.5126
- Q2 FY26: reported $0.12 per share against an estimate of $0.3564
LAZ news
- Press releasePRNewswire
- Press releasePRNewswire
Lazard Welcomes David Krap as Managing Director and Co-Head of European Consumer, Retail & Leisure
- Press releasePRNewswire
Lazard Reports September 2026 Assets Under Management
- Press releasePRNewswire
Lazard to Announce Third Quarter and Nine Month 2026 Financial Results
- Press releasePRNewswire
Pranjal Gambhir Joins Lazard as Head of Medical Technology
- Press releasePRNewswire
Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in August
- Press releasePRNewswire
Matt Spence Joins Lazard As Head of Defense Technology and Emerging Technology
- Press releasePRNewswire
Lazard Reports August 2026 Assets Under Management
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.